Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumigan vs Travatan in Patients on Latanoprost
NCT00440011Phase 4Completed
- Sponsor
- Allergan
- Start
- Aug 2006
- Primary completion
- Oct 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bimatoprost in Glaucoma and ocular hypertension, sponsored by Allergan. Primary endpoint: Intraocular Pressure at 3 months. Started Aug 2006; status: completed.
02
Drugs
bimatoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00440011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440011.